• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS SARS-COV-2 TEST; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS SARS-COV-2 TEST; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Catalog Number 09175431190
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Low Test Results (2458); Output Problem (3005)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/29/2020
Event Type  malfunction  
Manufacturer Narrative
The assay is working as intended.The issue alleged by the customer is most likely due to the samples being near or below the lod of the assay.Additionally, the complaint kit lot was tested and results met specifications.(b)(4).
 
Event Description
The agency has clarified its expectation that manufacturers of emergency use authorization (eua) products for sars-cov-2 diagnostic tests report allegations of false positive or false negative results independent of harm or malfunction or off-label use beyond 803s "reasonably suggests" requirements.Accordingly, we have performed a retrospective review of cases to determine whether to report any additional cases.A customer from (b)(6) alleged discrepant results with the cobas¿ sars-cov-2 assay.A review of the provided data confirmed that sample id (b)(6) generated a positive result for target 1 with a ct value of 36.5 and negative for target 2 and ic ct of 33.17.No harm or injury was indicated.A review of the positive growth curves showed a very flat curve with a late rise in fluorescence corresponding with the late ct values.Additionally, the ic does not appear to be delayed.The alleged runs contained valid roche controls and are in line with release data.The sample was retested with the cobas¿ sars-cov-2, cepheid, and altona realstar assays and all were negative.The retest data on the cobas¿ sars-cov-2 was not available to be provided.Information is not available regarding whether any of the results were reported to the patient.The customer confirmed that the assay was used for screening purposes.The samples were nasopharyngeal swabs collected in a utm collection media tube.The late ct value of 36.5 for target 1 is indicative of a sample near or below the limit of detection (lod) of the assay.As per table: lod determination using usa-wa1/2020 strain in the method sheet this would correspond to a hit rate of less than 38.1%.As such, results can waiver between positive and negative as observed here with the alleged samples.According to the instructions for use, the cobas sars-cov-2 for use on the cobas 6800/8800 systems is a real-time rt-pcr test intended for the qualitative detection of nucleic acids from sars-cov-2 in clinician-instructed self-collected nasal swab specimens (collected on site), and clinician-collected nasal, nasopharyngeal, and oropharyngeal swab specimens from individuals who meet covid-19 clinical and/or epidemiological criteria.The cobas sars-cov-2 is a qualitative test for use on the cobas 6800/8800 system for the detection of the 2019 novel coronavirus(sars-cov-2) rna in nasal, nasopharyngeal, and oropharyngeal swab samples collected in copan universal transport medium system (utm-rt),bd universal viral transport system (uvt), cobas pcr media, or 0.9% physiological saline.Based on the totality of the information and data provided, the assay is working as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS SARS-COV-2 TEST
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer (Section G)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
na
branchburg NJ 08876
Manufacturer Contact
stacie-ann creighton
1080 us hwy 202 s
na
branchburg, NJ 08876
9082537112
MDR Report Key10760389
MDR Text Key250175331
Report Number2243471-2020-00266
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
EUA200009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2021
Device Catalogue Number09175431190
Device Lot NumberG11392
Date Manufacturer Received09/02/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-